<DOC>
	<DOC>NCT01137032</DOC>
	<brief_summary>The purpose of this study is to determine the effect of PandelÂ® (hydrocortisone probutate cream) Cream 0.1% on the Hypothalamic Pituitary Adrenal (HPA) axis in pediatric and adult subjects with either psoriasis or atopic dermatitis involving greater than 20% body surface area.</brief_summary>
	<brief_title>Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Clinical diagnosis of psoriasis or atopic dermatitis involving more than 20% of body surface area Good health with the exception of psoriasis or atopic dermatitis Any disease affecting the HPAaxis Subjects who are pregnant, nursing, or planning a pregnancy within the study participation period</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Atopic Dermatitis</keyword>
</DOC>